Sarepta Therapeutics, Inc. (SRPT)
| Previous Close | 117.12 |
| Open | 117.66 |
| Bid | 124.00 x 100 |
| Ask | 124.35 x 100 |
| Day's Range | 117.21 - 125.13 |
| 52 Week Range | 55.25 - 159.89 |
| Volume | |
| Avg. Volume | 808,669 |
| Market Cap | 11.645B |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.79 |
| Earnings Date | May 01, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 165.89 |
Business WireSarepta Therapeutics to Announce First Quarter 2024 Financial Results
CAMBRIDGE, Mass., April 24, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2024 financial results.
Insider Monkey10 Unstoppable Stocks That Will Make You Richer
In this article, we discuss the 10 unstoppable stocks that will make you richer. To skip the detailed analysis of the economy and market, go directly to the 5 Unstoppable Stocks That Will Make You Richer. On April 12, the week closed out with stocks tumbling as the S&P 500 recorded its worst day since […]
Investor's Business DailyWhy Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst
Sarepta will likely miss first-quarter expectations, an analyst said Monday, noting Sarepta stock has taken a beating since its last report.
